awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28078993-6E068A95-517C-428F-B985-0D9BBFB241D1
Q28078993-6E068A95-517C-428F-B985-0D9BBFB241D1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28078993-6E068A95-517C-428F-B985-0D9BBFB241D1
Treatment of multiple myeloma with the immunostimulatory SLAMF7 antibody elotuzumab
P2860
Q28078993-6E068A95-517C-428F-B985-0D9BBFB241D1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28078993-6E068A95-517C-428F-B985-0D9BBFB241D1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
134bde0b40f5b58dd7cfb3baca0aa9f7bec67bbe
P2860
Phase I safety data of lenalidomide, bortezomib, dexamethasone, and elotuzumab as induction therapy for newly diagnosed symptomatic multiple myeloma: SWOG S1211.